# Florian Brand

> Florian Brand is a Series A investor at Prox Ventures backing Health Care and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Prox Ventures](https://shizune.co/investors/profile/prox-ventures)
- Location: Kreuzberg, Germany
- Total investments: 4
- Last investment: Jun 2022
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/brand-florian/
- X (Twitter): https://twitter.com/flobrand
- Website: https://x.com/flobrand
- Facebook: https://www.facebook.com/florian.brand

Florian Brand is a Series A investor at Prox Ventures in Kreuzberg focused on Health Care and Biotechnology. Florian Brand is based out of Berlin, Berlin and is the Founder of Prox Ventures. Florian previously worked at AtaiBeckley as a CEO and Co-Founder. Florian Brand attended ESCP Business School. Florian Brand has received the 40 under 40 award.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Biotechnology | 2 | 50% |
| Wellness | 1 | 25% |
| Life Science | 1 | 25% |
| Mental Health | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Series B | 1 | 25% |
| Post-IPO Debt | 1 | 25% |
| Post-IPO Equity | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 1 | 25% |
| Germany | 1 | 25% |
| United Kingdom | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kranus Health | Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently. | $6.5M | Series A | Jun 20, 2022 |  |
| IntelGenX | IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP,and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients. | $12.3M | Post-IPO Equity | Mar 15, 2021 |  |
| IntelGenX | IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP,and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients. | $2M | Post-IPO Debt | Mar 15, 2021 |  |
| COMPASS Pathways | Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing psilocybin therapy, a psychedelic compound found in certain mushrooms, as a potential treatment for depression.Compass Pathways conducts clinical trials and research toassess the safety and efficacy of psilocybin-assisted therapy in patients who have not responded to conventional depression treatments. The company's goal is to bring evidence-based innovation to mental health care and address the significant unmet need for effective and accessible treatments for depression. | $80M | Series B | Apr 27, 2020 |  |

4 of 4 investments shown.

## Co-investors
- [Able Partners](https://shizune.co/investors/profile/able-partners) — VC Fund, 1 deal together
- [A Round Capital](https://shizune.co/investors/profile/a-round-capital-d06f) — VC Fund, 1 deal together
- [Camden Partners](https://shizune.co/investors/profile/camden-partners) — VC Fund, 1 deal together
- [Founders Fund](https://shizune.co/investors/profile/founders-fund) — VC Fund, 1 deal together
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 1 deal together
- [Karista](https://shizune.co/investors/profile/karista) — VC Fund, 1 deal together

## About Prox Ventures

VC Fund · Shanghai, China

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

2 contacts available at Prox Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Florian Brand | Founder | https://shizune.co/investors/profile/florian-brand |
| Li Qian | Project leader | https://shizune.co/investors/profile/li-qian-c4e9 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Florian Brand invest in?

Florian Brand invests primarily in Health Care, Biotechnology and Wellness startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Florian Brand last invest?

The most recent investment recorded for Florian Brand closed in Jun 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co